Ambros Therapeutics Announces Notice of Allowance for New U.S. Patent Application Covering Neridronate for Complex Regional Pain Syndrome Type 1

Ambros Therapeutics, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a new U.S. patent application covering methods of selectively ...
IPWatchdog

How to Draft AI Patents That Survive the Next Guidance Cycle, and the One After That

Since 2024, the USPTO has issued multiple AI-specific guidance documents on inventorship and subject matter eligibility. The ...
Electrek

Tesla patent reveals dual-battery system for trailer-mounted range extender

A new Tesla patent filed in August 2024 details a dual-battery management system for an 800V/400V range extender — including ...

G-Stacker Developer Ferdinand Mehlinger Files Federal Patent Application as Search Engines Splinter Across Google

WILMINGTON, DE - March 27, 2026 - PRESSADVANTAGE - Ferdinand Mehlinger, founder and developer of G-Stacker, has ...
Interesting Engineering on MSN

US firm advances nuclear fuel design with new assembly patent for next-gen reactors

Lightbridge Corporation, a US-based leader in advanced nuclear fuel technology, has announced that it ...
Game Rant on MSN

Nintendo's character-summoning patent has been rejected

The U.S. Patent and Trademark Office deals Nintendo a legal blow in its patent pursuits over Pokemon's character-summoning ...